Mark S. Levine
Insider
First SEC filing: March 5, 2026 · Latest: March 5, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2024 | IMVT | S | 3,650 | $25.45 | $92,892 | 319,228 Direct | -1.13% | Disposed | 32.1% (price as of 2026-10-02) |
| Oct. 23, 2024 | IMVT | S | 4,361 | $29.53 | $128,780 | 322,878 Direct | -1.33% | Disposed | 13.9% (price as of 2026-10-02) |
| Oct. 16, 2024 | IMVT | S | 2,860 | $28.79 | $82,339 | 327,239 Direct | -0.87% | Disposed | 16.8% (price as of 2026-10-02) |
| Aug. 21, 2024 | IMVT | S | 3,164 | $31.84 | $100,742 | 330,230 Direct | -0.95% | Disposed | 5.6% (price as of 2026-10-02) |
| Aug. 21, 2024 | IMVT | S | 131 | $32.32 | $4,234 | 330,099 Direct | -0.04% | Disposed | 4.0% (price as of 2026-10-02) |
| July 24, 2024 | IMVT | S | 4,015 | $27.76 | $111,456 | 333,394 Direct | -1.19% | Disposed | 21.1% (price as of 2026-10-02) |
| July 17, 2024 | IMVT | S | 2,358 | $29.64 | $69,891 | 337,556 Direct | -0.69% | Disposed | 13.4% (price as of 2026-10-02) |
| July 17, 2024 | IMVT | S | 147 | $30.55 | $4,491 | 337,409 Direct | -0.04% | Disposed | 10.0% (price as of 2026-10-02) |
| May 22, 2024 | IMVT | S | 3,242 | $29.65 | $96,125 | 339,914 Direct | -0.94% | Disposed | 13.4% (price as of 2026-10-02) |
| April 24, 2024 | IMVT | S | 3,963 | $28.90 | $114,531 | 343,156 Direct | -1.14% | Disposed | 16.3% (price as of 2026-10-02) |
| April 17, 2024 | IMVT | S | 7,602 | $28.80 | $218,938 | 349,344 Direct | -2.13% | Disposed | 16.7% (price as of 2026-10-02) |
| April 17, 2024 | IMVT | S | 2,225 | $29.94 | $66,616 | 347,119 Direct | -0.64% | Disposed | 12.3% (price as of 2026-10-02) |
| April 2, 2024 | IMVT | A | 54,978 | · | · | 356,946 Direct | +18.21% | Acquired | (price as of 2026-10-02) |
| April 2, 2024 | IMVT | A | 68,723 | · | · | 68,723 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 22, 2024 | IMVT | S | 2,134 | $36.15 | $77,144 | 301,968 Direct | -0.70% | Disposed | -7.0% (price as of 2026-10-02) |
| Jan. 26, 2024 | IMVT | S | 2,981 | $37.91 | $113,010 | 304,148 Direct | -0.97% | Disposed | -11.3% (price as of 2026-10-02) |
| Jan. 26, 2024 | IMVT | S | 46 | $38.45 | $1,769 | 304,102 Direct | -0.02% | Disposed | -12.6% (price as of 2026-10-02) |
| Nov. 22, 2023 | IMVT | S | 3,128 | $32.75 | $102,442 | 307,253 Direct | -1.01% | Disposed | 2.7% (price as of 2026-10-02) |
| Nov. 22, 2023 | IMVT | S | 124 | $33.52 | $4,156 | 307,129 Direct | -0.04% | Disposed | 0.3% (price as of 2026-10-02) |
| Oct. 25, 2023 | IMVT | S | 4,107 | $34.66 | $142,349 | 310,381 Direct | -1.31% | Disposed | -3.0% (price as of 2026-10-02) |
| Aug. 24, 2023 | IMVT | S | 12,285 | $20.30 | $249,386 | 314,489 Direct | -3.76% | Disposed | 65.6% (price as of 2026-10-02) |
| Aug. 24, 2023 | IMVT | S | 1 | $20.89 | $21 | 314,488 Direct | 0.00% | Disposed | 60.9% (price as of 2026-10-02) |
| July 26, 2023 | IMVT | S | 3,917 | $21.63 | $84,725 | 326,774 Direct | -1.18% | Disposed | 55.4% (price as of 2026-10-02) |
| April 25, 2023 | IMVT | S | 2,633 | $16.29 | $42,892 | 330,691 Direct | -0.79% | Disposed | 106.4% (price as of 2026-10-02) |
| April 12, 2023 | IMVT | A | 87,664 | · | · | 333,324 Direct | +35.69% | Acquired | (price as of 2026-10-02) |
| April 12, 2023 | IMVT | A | 113,821 | · | · | 113,821 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 26, 2023 | IMVT | S | 10,156 | $18.51 | $187,988 | 245,660 Direct | -3.97% | Disposed | 81.6% (price as of 2026-10-02) |
| Aug. 17, 2022 | IMVT | A | 112,816 | · | · | 255,816 Direct | +78.89% | Acquired | (price as of 2026-10-02) |
| Aug. 17, 2022 | IMVT | A | 169,648 | · | · | 169,648 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 28, 2022 | IMVT | A | 143,000 | · | · | 143,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 28, 2022 | IMVT | A | 383,000 | · | · | 383,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 1, 2017 | NERV | M | 17,500 | · | · | 39,774 Direct | -30.55% | Disposed | (price as of 2026-10-02) |
| June 1, 2017 | NERV | S 10b5-1 | 17,500 | $11.00 | $192,500 | 0 Direct | -100.00% | Disposed | -96.3% (price as of 2026-10-02) |
| June 1, 2017 | NERV | M | 17,500 | $5.19 | $90,825 | 17,500 Direct | · | Acquired | -92.1% (price as of 2026-10-02) |
| Jan. 4, 2017 | NERV | M | 250 | · | · | 57,274 Direct | -0.43% | Disposed | (price as of 2026-10-02) |
| Jan. 4, 2017 | NERV | M | 17,250 | · | · | 51,750 Direct | -25.00% | Disposed | (price as of 2026-10-02) |
| Jan. 4, 2017 | NERV | S 10b5-1 | 17,500 | $12.00 | $210,000 | 0 Direct | -100.00% | Disposed | -96.6% (price as of 2026-10-02) |
| Jan. 4, 2017 | NERV | M | 250 | $5.19 | $1,298 | 17,500 Direct | +1.45% | Acquired | -92.1% (price as of 2026-10-02) |
| Jan. 4, 2017 | NERV | M | 17,250 | $4.71 | $81,248 | 17,250 Direct | · | Acquired | -91.3% (price as of 2026-10-02) |
| Dec. 14, 2016 | NERV | A | 20,000 | · | · | 20,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 14, 2016 | NERV | A | 35,000 | · | · | 35,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 4, 2015 | NERV | A | 69,000 | · | · | 69,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 14, 2015 | NERV | A | 57,524 | · | · | 57,524 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 2, 2014 | NERV | A | 93,541 | · | · | 93,541 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 2, 2024 | IMVT | Stock Option (right to buy) | Common Stock | $30.78 | April 2, 2034 | 68,723 | Acquired |
| April 12, 2023 | IMVT | Stock Option (right to buy) | Common Stock | $14.70 | April 12, 2033 | 113,821 | Acquired |
| Aug. 17, 2022 | IMVT | Stock Option (right to buy) | Common Stock | $4.99 | Aug. 17, 2032 | 169,648 | Acquired |
| Jan. 28, 2022 | IMVT | Stock Option (right to buy) | Common Stock | $6.72 | Jan. 28, 2032 | 383,000 | Acquired |
| June 1, 2017 | NERV | Employee Stock Option (Right to Buy) | Common Stock | $5.19 | April 13, 2025 | 17,500 | Disposed |
| Jan. 4, 2017 | NERV | Stock Option (Right to Buy) | Common Stock | $5.19 | April 13, 2025 | 250 | Disposed |
| Jan. 4, 2017 | NERV | Stock Option (Right to Buy) | Common Stock | $4.71 | Dec. 3, 2025 | 17,250 | Disposed |
| Dec. 14, 2016 | NERV | Restricted Stock Units | Common Stock | · | · | 20,000 | Acquired |
| Dec. 14, 2016 | NERV | Employee Stock Option (Right to Buy) | Common Stock | · | Dec. 13, 2026 | 35,000 | Acquired |
| Dec. 4, 2015 | NERV | Stock Option (right to buy) | Common Stock | · | Dec. 3, 2025 | 69,000 | Acquired |
| April 14, 2015 | NERV | Stock Option (right to buy) | Common Stock | · | April 13, 2025 | 57,524 | Acquired |
| Sept. 2, 2014 | NERV | Employee Stock Option (Right to Buy) | Common Stock | $7.10 | Sept. 2, 2024 | 93,541 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | · | · | · | · | · | · | · | · |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.